Drug Coated Coronary Balloon Catheter Industry Research Report 2025

Summary

According to APO Research, the global Drug Coated Coronary Balloon Catheter market was valued at US$ million in 2024 and is anticipated to reach US$ million by 2031, witnessing a CAGR of xx% during the forecast period 2025-2031.

North American market for Drug Coated Coronary Balloon Catheter is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Drug Coated Coronary Balloon Catheter is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Drug Coated Coronary Balloon Catheter is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Drug Coated Coronary Balloon Catheter include B.Braun, BD, Biotronik, Bonston Scientific, Concept Medical Inc, Eurocor Tech GmbH, Medronic, USM Healthcare and Zhejiang Barty Medical Technology, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Drug Coated Coronary Balloon Catheter, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Drug Coated Coronary Balloon Catheter.

The report will help the Drug Coated Coronary Balloon Catheter manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

The Drug Coated Coronary Balloon Catheter market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Drug Coated Coronary Balloon Catheter market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2020-2025. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.

Drug Coated Coronary Balloon Catheter Segment by Company

B.Braun
BD
Biotronik
Bonston Scientific
Concept Medical Inc
Eurocor Tech GmbH
Medronic
USM Healthcare
Zhejiang Barty Medical Technology
Blue Sail Medical
Lepu Medical Technology
Yinyi (Liaoning) Biotech
MicroPort
Acotec Scientific
GrandPharma(Cardionovum)
Drug Coated Coronary Balloon Catheter Segment by Type

Sirolimus
Beautiful Moss
Paclitaxel
Others
Drug Coated Coronary Balloon Catheter Segment by Application

Hospital
Clinic
Others
Drug Coated Coronary Balloon Catheter Segment by Region

North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Drug Coated Coronary Balloon Catheter market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Drug Coated Coronary Balloon Catheter and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Drug Coated Coronary Balloon Catheter.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Drug Coated Coronary Balloon Catheter manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Drug Coated Coronary Balloon Catheter by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Drug Coated Coronary Balloon Catheter in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.


1 Preface
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 Market Overview
2.1 Product Definition
2.2 Global Market Growth Prospects
2.2.1 Global Drug Coated Coronary Balloon Catheter Market Size (2020-2031)
2.2.2 Global Drug Coated Coronary Balloon Catheter Sales (2020-2031)
2.2.3 Global Drug Coated Coronary Balloon Catheter Market Average Price (2020-2031)
2.3 Drug Coated Coronary Balloon Catheter by Type
2.3.1 Market Value Comparison by Type (2020 VS 2024 VS 2031) & (US$ Million)
2.3.2 Sirolimus
2.3.3 Beautiful Moss
2.3.4 Paclitaxel
2.3.5 Others
2.4 Drug Coated Coronary Balloon Catheter by Application
2.4.1 Market Value Comparison by Application (2020 VS 2024 VS 2031)
2.4.2 Hospital
2.4.3 Clinic
2.4.4 Others
3 Market Competitive Landscape by Manufacturers
3.1 Global Drug Coated Coronary Balloon Catheter Market Competitive Situation by Manufacturers (2020 Versus 2024)
3.2 Global Drug Coated Coronary Balloon Catheter Sales (K Units) of Manufacturers (2020-2025)
3.3 Global Drug Coated Coronary Balloon Catheter Revenue of Manufacturers (2020-2025)
3.4 Global Drug Coated Coronary Balloon Catheter Average Price by Manufacturers (2020-2025)
3.5 Global Drug Coated Coronary Balloon Catheter Industry Ranking, 2023 VS 2024 VS 2025
3.6 Global Manufacturers of Drug Coated Coronary Balloon Catheter, Manufacturing Sites & Headquarters
3.7 Global Manufacturers of Drug Coated Coronary Balloon Catheter, Product Type & Application
3.8 Global Manufacturers of Drug Coated Coronary Balloon Catheter, Established Date
3.9 Global Drug Coated Coronary Balloon Catheter Market CR5 and HHI
3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
4.1 B.Braun
4.1.1 B.Braun Company Information
4.1.2 B.Braun Business Overview
4.1.3 B.Braun Drug Coated Coronary Balloon Catheter Sales, Revenue and Gross Margin (2020-2025)
4.1.4 B.Braun Drug Coated Coronary Balloon Catheter Product Portfolio
4.1.5 B.Braun Recent Developments
4.2 BD
4.2.1 BD Company Information
4.2.2 BD Business Overview
4.2.3 BD Drug Coated Coronary Balloon Catheter Sales, Revenue and Gross Margin (2020-2025)
4.2.4 BD Drug Coated Coronary Balloon Catheter Product Portfolio
4.2.5 BD Recent Developments
4.3 Biotronik
4.3.1 Biotronik Company Information
4.3.2 Biotronik Business Overview
4.3.3 Biotronik Drug Coated Coronary Balloon Catheter Sales, Revenue and Gross Margin (2020-2025)
4.3.4 Biotronik Drug Coated Coronary Balloon Catheter Product Portfolio
4.3.5 Biotronik Recent Developments
4.4 Bonston Scientific
4.4.1 Bonston Scientific Company Information
4.4.2 Bonston Scientific Business Overview
4.4.3 Bonston Scientific Drug Coated Coronary Balloon Catheter Sales, Revenue and Gross Margin (2020-2025)
4.4.4 Bonston Scientific Drug Coated Coronary Balloon Catheter Product Portfolio
4.4.5 Bonston Scientific Recent Developments
4.5 Concept Medical Inc
4.5.1 Concept Medical Inc Company Information
4.5.2 Concept Medical Inc Business Overview
4.5.3 Concept Medical Inc Drug Coated Coronary Balloon Catheter Sales, Revenue and Gross Margin (2020-2025)
4.5.4 Concept Medical Inc Drug Coated Coronary Balloon Catheter Product Portfolio
4.5.5 Concept Medical Inc Recent Developments
4.6 Eurocor Tech GmbH
4.6.1 Eurocor Tech GmbH Company Information
4.6.2 Eurocor Tech GmbH Business Overview
4.6.3 Eurocor Tech GmbH Drug Coated Coronary Balloon Catheter Sales, Revenue and Gross Margin (2020-2025)
4.6.4 Eurocor Tech GmbH Drug Coated Coronary Balloon Catheter Product Portfolio
4.6.5 Eurocor Tech GmbH Recent Developments
4.7 Medronic
4.7.1 Medronic Company Information
4.7.2 Medronic Business Overview
4.7.3 Medronic Drug Coated Coronary Balloon Catheter Sales, Revenue and Gross Margin (2020-2025)
4.7.4 Medronic Drug Coated Coronary Balloon Catheter Product Portfolio
4.7.5 Medronic Recent Developments
4.8 USM Healthcare
4.8.1 USM Healthcare Company Information
4.8.2 USM Healthcare Business Overview
4.8.3 USM Healthcare Drug Coated Coronary Balloon Catheter Sales, Revenue and Gross Margin (2020-2025)
4.8.4 USM Healthcare Drug Coated Coronary Balloon Catheter Product Portfolio
4.8.5 USM Healthcare Recent Developments
4.9 Zhejiang Barty Medical Technology
4.9.1 Zhejiang Barty Medical Technology Company Information
4.9.2 Zhejiang Barty Medical Technology Business Overview
4.9.3 Zhejiang Barty Medical Technology Drug Coated Coronary Balloon Catheter Sales, Revenue and Gross Margin (2020-2025)
4.9.4 Zhejiang Barty Medical Technology Drug Coated Coronary Balloon Catheter Product Portfolio
4.9.5 Zhejiang Barty Medical Technology Recent Developments
4.10 Blue Sail Medical
4.10.1 Blue Sail Medical Company Information
4.10.2 Blue Sail Medical Business Overview
4.10.3 Blue Sail Medical Drug Coated Coronary Balloon Catheter Sales, Revenue and Gross Margin (2020-2025)
4.10.4 Blue Sail Medical Drug Coated Coronary Balloon Catheter Product Portfolio
4.10.5 Blue Sail Medical Recent Developments
4.11 Lepu Medical Technology
4.11.1 Lepu Medical Technology Company Information
4.11.2 Lepu Medical Technology Business Overview
4.11.3 Lepu Medical Technology Drug Coated Coronary Balloon Catheter Sales, Revenue and Gross Margin (2020-2025)
4.11.4 Lepu Medical Technology Drug Coated Coronary Balloon Catheter Product Portfolio
4.11.5 Lepu Medical Technology Recent Developments
4.12 Yinyi (Liaoning) Biotech
4.12.1 Yinyi (Liaoning) Biotech Company Information
4.12.2 Yinyi (Liaoning) Biotech Business Overview
4.12.3 Yinyi (Liaoning) Biotech Drug Coated Coronary Balloon Catheter Sales, Revenue and Gross Margin (2020-2025)
4.12.4 Yinyi (Liaoning) Biotech Drug Coated Coronary Balloon Catheter Product Portfolio
4.12.5 Yinyi (Liaoning) Biotech Recent Developments
4.13 MicroPort
4.13.1 MicroPort Company Information
4.13.2 MicroPort Business Overview
4.13.3 MicroPort Drug Coated Coronary Balloon Catheter Sales, Revenue and Gross Margin (2020-2025)
4.13.4 MicroPort Drug Coated Coronary Balloon Catheter Product Portfolio
4.13.5 MicroPort Recent Developments
4.14 Acotec Scientific
4.14.1 Acotec Scientific Company Information
4.14.2 Acotec Scientific Business Overview
4.14.3 Acotec Scientific Drug Coated Coronary Balloon Catheter Sales, Revenue and Gross Margin (2020-2025)
4.14.4 Acotec Scientific Drug Coated Coronary Balloon Catheter Product Portfolio
4.14.5 Acotec Scientific Recent Developments
4.15 GrandPharma(Cardionovum)
4.15.1 GrandPharma(Cardionovum) Company Information
4.15.2 GrandPharma(Cardionovum) Business Overview
4.15.3 GrandPharma(Cardionovum) Drug Coated Coronary Balloon Catheter Sales, Revenue and Gross Margin (2020-2025)
4.15.4 GrandPharma(Cardionovum) Drug Coated Coronary Balloon Catheter Product Portfolio
4.15.5 GrandPharma(Cardionovum) Recent Developments
5 Global Drug Coated Coronary Balloon Catheter Market Scenario by Region
5.1 Global Drug Coated Coronary Balloon Catheter Market Size by Region: 2020 VS 2024 VS 2031
5.2 Global Drug Coated Coronary Balloon Catheter Sales by Region: 2020-2031
5.2.1 Global Drug Coated Coronary Balloon Catheter Sales by Region: 2020-2025
5.2.2 Global Drug Coated Coronary Balloon Catheter Sales by Region: 2026-2031
5.3 Global Drug Coated Coronary Balloon Catheter Revenue by Region: 2020-2031
5.3.1 Global Drug Coated Coronary Balloon Catheter Revenue by Region: 2020-2025
5.3.2 Global Drug Coated Coronary Balloon Catheter Revenue by Region: 2026-2031
5.4 North America Drug Coated Coronary Balloon Catheter Market Facts & Figures by Country
5.4.1 North America Drug Coated Coronary Balloon Catheter Market Size by Country: 2020 VS 2024 VS 2031
5.4.2 North America Drug Coated Coronary Balloon Catheter Sales by Country (2020-2031)
5.4.3 North America Drug Coated Coronary Balloon Catheter Revenue by Country (2020-2031)
5.4.4 United States
5.4.5 Canada
5.4.6 Mexico
5.5 Europe Drug Coated Coronary Balloon Catheter Market Facts & Figures by Country
5.5.1 Europe Drug Coated Coronary Balloon Catheter Market Size by Country: 2020 VS 2024 VS 2031
5.5.2 Europe Drug Coated Coronary Balloon Catheter Sales by Country (2020-2031)
5.5.3 Europe Drug Coated Coronary Balloon Catheter Revenue by Country (2020-2031)
5.5.4 Germany
5.5.5 France
5.5.6 U.K.
5.5.7 Italy
5.5.8 Russia
5.5.9 Spain
5.5.10 Netherlands
5.5.11 Switzerland
5.5.12 Sweden
5.5.13 Poland
5.6 Asia Pacific Drug Coated Coronary Balloon Catheter Market Facts & Figures by Country
5.6.1 Asia Pacific Drug Coated Coronary Balloon Catheter Market Size by Country: 2020 VS 2024 VS 2031
5.6.2 Asia Pacific Drug Coated Coronary Balloon Catheter Sales by Country (2020-2031)
5.6.3 Asia Pacific Drug Coated Coronary Balloon Catheter Revenue by Country (2020-2031)
5.6.4 China
5.6.5 Japan
5.6.6 South Korea
5.6.7 India
5.6.8 Australia
5.6.9 Taiwan
5.6.10 Southeast Asia
5.7 South America Drug Coated Coronary Balloon Catheter Market Facts & Figures by Country
5.7.1 South America Drug Coated Coronary Balloon Catheter Market Size by Country: 2020 VS 2024 VS 2031
5.7.2 South America Drug Coated Coronary Balloon Catheter Sales by Country (2020-2031)
5.7.3 South America Drug Coated Coronary Balloon Catheter Revenue by Country (2020-2031)
5.7.4 Brazil
5.7.5 Argentina
5.7.6 Chile
5.8 Middle East and Africa Drug Coated Coronary Balloon Catheter Market Facts & Figures by Country
5.8.1 Middle East and Africa Drug Coated Coronary Balloon Catheter Market Size by Country: 2020 VS 2024 VS 2031
5.8.2 Middle East and Africa Drug Coated Coronary Balloon Catheter Sales by Country (2020-2031)
5.8.3 Middle East and Africa Drug Coated Coronary Balloon Catheter Revenue by Country (2020-2031)
5.8.4 Egypt
5.8.5 South Africa
5.8.6 Israel
5.8.7 Türkiye
5.8.8 GCC Countries
6 Segment by Type
6.1 Global Drug Coated Coronary Balloon Catheter Sales by Type (2020-2031)
6.1.1 Global Drug Coated Coronary Balloon Catheter Sales by Type (2020-2031) & (K Units)
6.1.2 Global Drug Coated Coronary Balloon Catheter Sales Market Share by Type (2020-2031)
6.2 Global Drug Coated Coronary Balloon Catheter Revenue by Type (2020-2031)
6.2.1 Global Drug Coated Coronary Balloon Catheter Sales by Type (2020-2031) & (US$ Million)
6.2.2 Global Drug Coated Coronary Balloon Catheter Revenue Market Share by Type (2020-2031)
6.3 Global Drug Coated Coronary Balloon Catheter Price by Type (2020-2031)
7 Segment by Application
7.1 Global Drug Coated Coronary Balloon Catheter Sales by Application (2020-2031)
7.1.1 Global Drug Coated Coronary Balloon Catheter Sales by Application (2020-2031) & (K Units)
7.1.2 Global Drug Coated Coronary Balloon Catheter Sales Market Share by Application (2020-2031)
7.2 Global Drug Coated Coronary Balloon Catheter Revenue by Application (2020-2031)
7.2.1 Global Drug Coated Coronary Balloon Catheter Sales by Application (2020-2031) & (US$ Million)
7.2.2 Global Drug Coated Coronary Balloon Catheter Revenue Market Share by Application (2020-2031)
7.3 Global Drug Coated Coronary Balloon Catheter Price by Application (2020-2031)
8 Value Chain and Sales Channels Analysis of the Market
8.1 Drug Coated Coronary Balloon Catheter Value Chain Analysis
8.1.1 Drug Coated Coronary Balloon Catheter Key Raw Materials
8.1.2 Raw Materials Key Suppliers
8.1.3 Drug Coated Coronary Balloon Catheter Production Mode & Process
8.2 Drug Coated Coronary Balloon Catheter Sales Channels Analysis
8.2.1 Direct Comparison with Distribution Share
8.2.2 Drug Coated Coronary Balloon Catheter Distributors
8.2.3 Drug Coated Coronary Balloon Catheter Customers
9 Global Drug Coated Coronary Balloon Catheter Analyzing Market Dynamics
9.1 Drug Coated Coronary Balloon Catheter Industry Trends
9.2 Drug Coated Coronary Balloon Catheter Industry Drivers
9.3 Drug Coated Coronary Balloon Catheter Industry Opportunities and Challenges
9.4 Drug Coated Coronary Balloon Catheter Industry Restraints
10 Report Conclusion
11 Disclaimer
List of Tables
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Type (2020 VS 2024 VS 2031) & (US$ Million)
Table 4. Market Value Comparison by Application (2020 VS 2024 VS 2031) & (US$ Million)
Table 5. Global Drug Coated Coronary Balloon Catheter Volume and Revenue Market Size and CAGR of Manufacturers (2020 Versus 2024)
Table 6. Global Drug Coated Coronary Balloon Catheter Sales (K Units) of Manufacturers (2020-2025)
Table 7. Global Drug Coated Coronary Balloon Catheter Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Drug Coated Coronary Balloon Catheter Revenue of Manufacturers (2020-2025)
Table 9. Global Drug Coated Coronary Balloon Catheter Revenue Share by Manufacturers (2020-2025)
Table 10. Global Market Drug Coated Coronary Balloon Catheter Average Price (US$/Unit) of Manufacturers (2020-2025)
Table 11. Global Drug Coated Coronary Balloon Catheter Industry Ranking, 2023 VS 2024 VS 2025
Table 12. Global Manufacturers of Drug Coated Coronary Balloon Catheter, Manufacturing Sites & Headquarters
Table 13. Global Manufacturers of Drug Coated Coronary Balloon Catheter, Product Type & Application
Table 14. Global Drug Coated Coronary Balloon Catheter Manufacturers Established Date
Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 16. Global Drug Coated Coronary Balloon Catheter by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2024)
Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans)
Table 18. B.Braun Company Information
Table 19. B.Braun Business Overview
Table 20. B.Braun Drug Coated Coronary Balloon Catheter Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 21. B.Braun Drug Coated Coronary Balloon Catheter Product Portfolio
Table 22. B.Braun Recent Developments
Table 23. BD Company Information
Table 24. BD Business Overview
Table 25. BD Drug Coated Coronary Balloon Catheter Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 26. BD Drug Coated Coronary Balloon Catheter Product Portfolio
Table 27. BD Recent Developments
Table 28. Biotronik Company Information
Table 29. Biotronik Business Overview
Table 30. Biotronik Drug Coated Coronary Balloon Catheter Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 31. Biotronik Drug Coated Coronary Balloon Catheter Product Portfolio
Table 32. Biotronik Recent Developments
Table 33. Bonston Scientific Company Information
Table 34. Bonston Scientific Business Overview
Table 35. Bonston Scientific Drug Coated Coronary Balloon Catheter Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 36. Bonston Scientific Drug Coated Coronary Balloon Catheter Product Portfolio
Table 37. Bonston Scientific Recent Developments
Table 38. Concept Medical Inc Company Information
Table 39. Concept Medical Inc Business Overview
Table 40. Concept Medical Inc Drug Coated Coronary Balloon Catheter Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 41. Concept Medical Inc Drug Coated Coronary Balloon Catheter Product Portfolio
Table 42. Concept Medical Inc Recent Developments
Table 43. Eurocor Tech GmbH Company Information
Table 44. Eurocor Tech GmbH Business Overview
Table 45. Eurocor Tech GmbH Drug Coated Coronary Balloon Catheter Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 46. Eurocor Tech GmbH Drug Coated Coronary Balloon Catheter Product Portfolio
Table 47. Eurocor Tech GmbH Recent Developments
Table 48. Medronic Company Information
Table 49. Medronic Business Overview
Table 50. Medronic Drug Coated Coronary Balloon Catheter Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 51. Medronic Drug Coated Coronary Balloon Catheter Product Portfolio
Table 52. Medronic Recent Developments
Table 53. USM Healthcare Company Information
Table 54. USM Healthcare Business Overview
Table 55. USM Healthcare Drug Coated Coronary Balloon Catheter Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 56. USM Healthcare Drug Coated Coronary Balloon Catheter Product Portfolio
Table 57. USM Healthcare Recent Developments
Table 58. Zhejiang Barty Medical Technology Company Information
Table 59. Zhejiang Barty Medical Technology Business Overview
Table 60. Zhejiang Barty Medical Technology Drug Coated Coronary Balloon Catheter Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 61. Zhejiang Barty Medical Technology Drug Coated Coronary Balloon Catheter Product Portfolio
Table 62. Zhejiang Barty Medical Technology Recent Developments
Table 63. Blue Sail Medical Company Information
Table 64. Blue Sail Medical Business Overview
Table 65. Blue Sail Medical Drug Coated Coronary Balloon Catheter Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 66. Blue Sail Medical Drug Coated Coronary Balloon Catheter Product Portfolio
Table 67. Blue Sail Medical Recent Developments
Table 68. Lepu Medical Technology Company Information
Table 69. Lepu Medical Technology Business Overview
Table 70. Lepu Medical Technology Drug Coated Coronary Balloon Catheter Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 71. Lepu Medical Technology Drug Coated Coronary Balloon Catheter Product Portfolio
Table 72. Lepu Medical Technology Recent Developments
Table 73. Yinyi (Liaoning) Biotech Company Information
Table 74. Yinyi (Liaoning) Biotech Business Overview
Table 75. Yinyi (Liaoning) Biotech Drug Coated Coronary Balloon Catheter Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 76. Yinyi (Liaoning) Biotech Drug Coated Coronary Balloon Catheter Product Portfolio
Table 77. Yinyi (Liaoning) Biotech Recent Developments
Table 78. MicroPort Company Information
Table 79. MicroPort Business Overview
Table 80. MicroPort Drug Coated Coronary Balloon Catheter Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 81. MicroPort Drug Coated Coronary Balloon Catheter Product Portfolio
Table 82. MicroPort Recent Developments
Table 83. Acotec Scientific Company Information
Table 84. Acotec Scientific Business Overview
Table 85. Acotec Scientific Drug Coated Coronary Balloon Catheter Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 86. Acotec Scientific Drug Coated Coronary Balloon Catheter Product Portfolio
Table 87. Acotec Scientific Recent Developments
Table 88. GrandPharma(Cardionovum) Company Information
Table 89. GrandPharma(Cardionovum) Business Overview
Table 90. GrandPharma(Cardionovum) Drug Coated Coronary Balloon Catheter Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 91. GrandPharma(Cardionovum) Drug Coated Coronary Balloon Catheter Product Portfolio
Table 92. GrandPharma(Cardionovum) Recent Developments
Table 93. Global Drug Coated Coronary Balloon Catheter Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 94. Global Drug Coated Coronary Balloon Catheter Sales by Region (2020-2025) & (K Units)
Table 95. Global Drug Coated Coronary Balloon Catheter Sales Market Share by Region (2020-2025)
Table 96. Global Drug Coated Coronary Balloon Catheter Sales by Region (2026-2031) & (K Units)
Table 97. Global Drug Coated Coronary Balloon Catheter Sales Market Share by Region (2026-2031)
Table 98. Global Drug Coated Coronary Balloon Catheter Revenue by Region (2020-2025) & (US$ Million)
Table 99. Global Drug Coated Coronary Balloon Catheter Revenue Market Share by Region (2020-2025)
Table 100. Global Drug Coated Coronary Balloon Catheter Revenue by Region (2026-2031) & (US$ Million)
Table 101. Global Drug Coated Coronary Balloon Catheter Revenue Market Share by Region (2026-2031)
Table 102. North America Drug Coated Coronary Balloon Catheter Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 103. North America Drug Coated Coronary Balloon Catheter Sales by Country (2020-2025) & (K Units)
Table 104. North America Drug Coated Coronary Balloon Catheter Sales by Country (2026-2031) & (K Units)
Table 105. North America Drug Coated Coronary Balloon Catheter Revenue by Country (2020-2025) & (US$ Million)
Table 106. North America Drug Coated Coronary Balloon Catheter Revenue by Country (2026-2031) & (US$ Million)
Table 107. Europe Drug Coated Coronary Balloon Catheter Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 108. Europe Drug Coated Coronary Balloon Catheter Sales by Country (2020-2025) & (K Units)
Table 109. Europe Drug Coated Coronary Balloon Catheter Sales by Country (2026-2031) & (K Units)
Table 110. Europe Drug Coated Coronary Balloon Catheter Revenue by Country (2020-2025) & (US$ Million)
Table 111. Europe Drug Coated Coronary Balloon Catheter Revenue by Country (2026-2031) & (US$ Million)
Table 112. Asia Pacific Drug Coated Coronary Balloon Catheter Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 113. Asia Pacific Drug Coated Coronary Balloon Catheter Sales by Country (2020-2025) & (K Units)
Table 114. Asia Pacific Drug Coated Coronary Balloon Catheter Sales by Country (2026-2031) & (K Units)
Table 115. Asia Pacific Drug Coated Coronary Balloon Catheter Revenue by Country (2020-2025) & (US$ Million)
Table 116. Asia Pacific Drug Coated Coronary Balloon Catheter Revenue by Country (2026-2031) & (US$ Million)
Table 117. South America Drug Coated Coronary Balloon Catheter Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 118. South America Drug Coated Coronary Balloon Catheter Sales by Country (2020-2025) & (K Units)
Table 119. South America Drug Coated Coronary Balloon Catheter Sales by Country (2026-2031) & (K Units)
Table 120. South America Drug Coated Coronary Balloon Catheter Revenue by Country (2020-2025) & (US$ Million)
Table 121. South America Drug Coated Coronary Balloon Catheter Revenue by Country (2026-2031) & (US$ Million)
Table 122. Middle East and Africa Drug Coated Coronary Balloon Catheter Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 123. Middle East and Africa Drug Coated Coronary Balloon Catheter Sales by Country (2020-2025) & (K Units)
Table 124. Middle East and Africa Drug Coated Coronary Balloon Catheter Sales by Country (2026-2031) & (K Units)
Table 125. Middle East and Africa Drug Coated Coronary Balloon Catheter Revenue by Country (2020-2025) & (US$ Million)
Table 126. Middle East and Africa Drug Coated Coronary Balloon Catheter Revenue by Country (2026-2031) & (US$ Million)
Table 127. Global Drug Coated Coronary Balloon Catheter Sales by Type (2020-2025) & (K Units)
Table 128. Global Drug Coated Coronary Balloon Catheter Sales by Type (2026-2031) & (K Units)
Table 129. Global Drug Coated Coronary Balloon Catheter Sales Market Share by Type (2020-2025)
Table 130. Global Drug Coated Coronary Balloon Catheter Sales Market Share by Type (2026-2031)
Table 131. Global Drug Coated Coronary Balloon Catheter Revenue by Type (2020-2025) & (US$ Million)
Table 132. Global Drug Coated Coronary Balloon Catheter Revenue by Type (2026-2031) & (US$ Million)
Table 133. Global Drug Coated Coronary Balloon Catheter Revenue Market Share by Type (2020-2025)
Table 134. Global Drug Coated Coronary Balloon Catheter Revenue Market Share by Type (2026-2031)
Table 135. Global Drug Coated Coronary Balloon Catheter Price by Type (2020-2025) & (US$/Unit)
Table 136. Global Drug Coated Coronary Balloon Catheter Price by Type (2026-2031) & (US$/Unit)
Table 137. Global Drug Coated Coronary Balloon Catheter Sales by Application (2020-2025) & (K Units)
Table 138. Global Drug Coated Coronary Balloon Catheter Sales by Application (2026-2031) & (K Units)
Table 139. Global Drug Coated Coronary Balloon Catheter Sales Market Share by Application (2020-2025)
Table 140. Global Drug Coated Coronary Balloon Catheter Sales Market Share by Application (2026-2031)
Table 141. Global Drug Coated Coronary Balloon Catheter Revenue by Application (2020-2025) & (US$ Million)
Table 142. Global Drug Coated Coronary Balloon Catheter Revenue by Application (2026-2031) & (US$ Million)
Table 143. Global Drug Coated Coronary Balloon Catheter Revenue Market Share by Application (2020-2025)
Table 144. Global Drug Coated Coronary Balloon Catheter Revenue Market Share by Application (2026-2031)
Table 145. Global Drug Coated Coronary Balloon Catheter Price by Application (2020-2025) & (US$/Unit)
Table 146. Global Drug Coated Coronary Balloon Catheter Price by Application (2026-2031) & (US$/Unit)
Table 147. Key Raw Materials
Table 148. Raw Materials Key Suppliers
Table 149. Drug Coated Coronary Balloon Catheter Distributors List
Table 150. Drug Coated Coronary Balloon Catheter Customers List
Table 151. Drug Coated Coronary Balloon Catheter Industry Trends
Table 152. Drug Coated Coronary Balloon Catheter Industry Drivers
Table 153. Drug Coated Coronary Balloon Catheter Industry Restraints
Table 154. Authors List of This Report
List of Figures
Figure 1. Research Methodology
Figure 2. Research Process
Figure 3. Key Executives Interviewed
Figure 4. Drug Coated Coronary Balloon Catheter Product Image
Figure 5. Global Drug Coated Coronary Balloon Catheter Revenue (US$ Million), 2020 VS 2024 VS 2031
Figure 6. Global Drug Coated Coronary Balloon Catheter Market Size (2020-2031) & (US$ Million)
Figure 7. Global Drug Coated Coronary Balloon Catheter Sales (2020-2031) & (K Units)
Figure 8. Global Drug Coated Coronary Balloon Catheter Average Price (US$/Unit) & (2020-2031)
Figure 9. Sirolimus Product Image
Figure 10. Beautiful Moss Product Image
Figure 11. Paclitaxel Product Image
Figure 12. Others Product Image
Figure 13. Hospital Product Image
Figure 14. Clinic Product Image
Figure 15. Others Product Image
Figure 16. Global Drug Coated Coronary Balloon Catheter Revenue Share by Manufacturers in 2024
Figure 17. Global Manufacturers of Drug Coated Coronary Balloon Catheter, Manufacturing Sites & Headquarters
Figure 18. Global Top 5 and 10 Drug Coated Coronary Balloon Catheter Players Market Share by Revenue in 2024
Figure 19. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 20. Global Drug Coated Coronary Balloon Catheter Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 21. Global Drug Coated Coronary Balloon Catheter Sales by Region in 2024
Figure 22. Global Drug Coated Coronary Balloon Catheter Revenue by Region in 2024
Figure 23. North America Drug Coated Coronary Balloon Catheter Market Size by Country in 2024
Figure 24. North America Drug Coated Coronary Balloon Catheter Sales Market Share by Country (2020-2031)
Figure 25. North America Drug Coated Coronary Balloon Catheter Revenue Market Share by Country (2020-2031)
Figure 26. United States Drug Coated Coronary Balloon Catheter Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 27. Canada Drug Coated Coronary Balloon Catheter Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. Mexico Drug Coated Coronary Balloon Catheter Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. Europe Drug Coated Coronary Balloon Catheter Market Size by Country in 2024
Figure 30. Europe Drug Coated Coronary Balloon Catheter Sales Market Share by Country (2020-2031)
Figure 31. Europe Drug Coated Coronary Balloon Catheter Revenue Market Share by Country (2020-2031)
Figure 32. Germany Drug Coated Coronary Balloon Catheter Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. France Drug Coated Coronary Balloon Catheter Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. U.K. Drug Coated Coronary Balloon Catheter Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Italy Drug Coated Coronary Balloon Catheter Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. Russia Drug Coated Coronary Balloon Catheter Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. Spain Drug Coated Coronary Balloon Catheter Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. Netherlands Drug Coated Coronary Balloon Catheter Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. Switzerland Drug Coated Coronary Balloon Catheter Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Sweden Drug Coated Coronary Balloon Catheter Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Poland Drug Coated Coronary Balloon Catheter Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Asia Pacific Drug Coated Coronary Balloon Catheter Market Size by Country in 2024
Figure 43. Asia Pacific Drug Coated Coronary Balloon Catheter Sales Market Share by Country (2020-2031)
Figure 44. Asia Pacific Drug Coated Coronary Balloon Catheter Revenue Market Share by Country (2020-2031)
Figure 45. China Drug Coated Coronary Balloon Catheter Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Japan Drug Coated Coronary Balloon Catheter Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. South Korea Drug Coated Coronary Balloon Catheter Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. India Drug Coated Coronary Balloon Catheter Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Australia Drug Coated Coronary Balloon Catheter Revenue Growth Rate (2020-2031) & (US$ Million)

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings